AI mobile app improves on ‘subjective’ patient-reported stool assessment in IBS

SAN DIEGO — A smartphone app using artificial intelligence was more effective than patient reporting in assessing stool samples in a cohort of individuals with irritable bowel syndrome, according to data presented at Digestive Diseases Week.“In IBS, the outcome measure that the FDA has determined for using their guidance relies on the patients reporting an improvement in stool consistency, regardless of whether you are constipated or have diarrhea,” Mark Pimentel, MD, of the GI Motility Program at Cedars-Sinai Medical Center, in Los Angeles, told Healio. “The problemRead More